Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

École Polytechnique de Montréal

$24,830.00

Multimodal and multispectral microscopy for clinical diagnostics

FY 2012-13

Summary
Current diagnoses of pathologies such as cancer rely on cellular evaluation of tissue samples excised through biopsy procedures. While this technique allows for evaluation of diseased cells, biopsies are uncomfortable for the patient, often hazardous, sample processing is time-consuming, and only a limited portion of a much larger organ is evaluated, resulting in a number of false-negative diagnoses. Optical imaging technologies such as optical coherence tomography (OCT) and reflectance confocal microscopy (RCM) are non-invasive optical technologies capable of producing high resolution images of cells at different depth through small, fibre-optics based instruments. The recent developments in biophotonics research have led to new smaller, more sensitive instruments having imaging speeds that allow non-invasive investigation of larger areas, reducing the risks associated with biopsies. Within the last decade, both these technologies (RCM and OCT) were shown to yield high quality structural (OCT), cellular and sub-cellular (RCM) images in vivo. However, the lack of specific contrast agents that would reproduce the effect of stains used on biopsy samples, limits their clinical utility to the few organs on which biopsies are impracticable. The objective of the proposed research program is to exploit linear and non-linear photon-tissue interactions to increase contrast and specificity of clinical microscopy images in ways that are compatible with constraints associated with the geometry of imaging endoscopes. The originality of this approach consists in combining tools traditionally used by biologists with newly developed optical diagnostics tools to yield high-resolution non-invasive endoscopic imaging with highly specific contrast. The research program includes the development of photonics tools that will enable the rapid transfer to the clinics, and lead to the development of the next generation of medical imaging endoscopes capable of non-invasively imaging human organs in vivo with cellular sensitivity and molecular specificity. These novel optical diagnostics technologies will provide enhanced diagnostics capability, allowing detection of diseases at earlier stages, where chances of survival and cure are the greatest.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
341555-2008
Name nom
Boudoux, Caroline
Department département
Génie physique
Organization id
64
Institution établissement
École Polytechnique de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2008
Award amount
24830
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
335
Committee name en
Electromag. & Electr. Systems (H)
Committee name fr
Électromagn. et syst. électr. (H)
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
3112
Research subject group en
Physics
Research subject group fr
Physique
Research subject en
Photonics
Research subject fr
Photonique
Partie
5
Nb partie
5
Application title
Multimodal and multispectral microscopy for clinical diagnostics
Keyword
NSERC
Application summary
Current diagnoses of pathologies such as cancer rely on cellular evaluation of tissue samples excised through biopsy procedures. While this technique allows for evaluation of diseased cells, biopsies are uncomfortable for the patient, often hazardous, sample processing is time-consuming, and only a limited portion of a much larger organ is evaluated, resulting in a number of false-negative diagnoses. Optical imaging technologies such as optical coherence tomography (OCT) and reflectance confocal microscopy (RCM) are non-invasive optical technologies capable of producing high resolution images of cells at different depth through small, fibre-optics based instruments. The recent developments in biophotonics research have led to new smaller, more sensitive instruments having imaging speeds that allow non-invasive investigation of larger areas, reducing the risks associated with biopsies. Within the last decade, both these technologies (RCM and OCT) were shown to yield high quality structural (OCT), cellular and sub-cellular (RCM) images in vivo. However, the lack of specific contrast agents that would reproduce the effect of stains used on biopsy samples, limits their clinical utility to the few organs on which biopsies are impracticable. The objective of the proposed research program is to exploit linear and non-linear photon-tissue interactions to increase contrast and specificity of clinical microscopy images in ways that are compatible with constraints associated with the geometry of imaging endoscopes. The originality of this approach consists in combining tools traditionally used by biologists with newly developed optical diagnostics tools to yield high-resolution non-invasive endoscopic imaging with highly specific contrast. The research program includes the development of photonics tools that will enable the rapid transfer to the clinics, and lead to the development of the next generation of medical imaging endoscopes capable of non-invasively imaging human organs in vivo with cellular sensitivity and molecular specificity. These novel optical diagnostics technologies will provide enhanced diagnostics capability, allowing detection of diseases at earlier stages, where chances of survival and cure are the greatest.